Clinical Trial Update: A Phase I Study of Nilontinib and Cetuximab in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

Phase I study evaluating Nilontinib in combination with cetuximab in patients with solid tumors, including colorectal cancer and head and neck cancer; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Nilontinib

Snippet

Sponsor: Georgetown University | Conditions: Colorectal Cancer, Head and Neck Cancer | Phase 1 | Status: TERMINATED